Synthesis and Mixed Lineage Kinase Activity of Pyrrolocarbazole and Isoindolone Analogs of (+)K-252a

Journal of Medicinal Chemistry
2007.0

Abstract

Structural modification of the indolecarbazole natural product (+)K-252a identified structural requirements for MLK activity and a novel series of potent fused pyrrolocarbazole MLK1/3 inhibitors. The SAR revealed that the lactam regiochemistry, the shape of the heterocycle, and aryl rings B and F are important to MLK activity. Heteroatom and alkyl replacement of the N-12 and/or N-13 indole nitrogen atoms identified the nonplanar dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-7-one (8) and corresponding 5,7-dione (7) as potent cell-permeable MLK1/3 family-selective leads with in vitro activity comparable to that of (+)K-252a and determined them to be 2- to 3-fold more potent than the aglycone natural product K-252c.

Knowledge Graph

Similar Paper

Synthesis and Mixed Lineage Kinase Activity of Pyrrolocarbazole and Isoindolone Analogs of (+)K-252a
Journal of Medicinal Chemistry 2007.0
Indolocarbazoles. 1. Total synthesis and protein kinase inhibiting characteristics of compounds related to K-252c.
Bioorganic & Medicinal Chemistry Letters 1993.0
Synthesis and biological activity of pyrazole analogues of the staurosporine aglycon K252c
Bioorganic & Medicinal Chemistry 2016.0
Indolocarbazoles.3. Synthesis of novel aza analogs of staurosporine and K 252a as PKC inhibitors.
Bioorganic & Medicinal Chemistry Letters 1994.0
Studies on cyclin-dependent kinase inhibitors: indolo-[2,3- a ]pyrrolo[3,4- c ]carbazoles versus bis-indolylmaleimides
Bioorganic & Medicinal Chemistry Letters 2003.0
Synthesis, checkpoint kinase 1 inhibitory properties and in vitro antiproliferative activities of new pyrrolocarbazoles
Bioorganic & Medicinal Chemistry 2008.0
Precursor-Directed Generation of Indolocarbazoles with Topoisomerase IIα Inhibitory Activity
Marine Drugs 2018.0
Novel indolocarbazole protein kinase c inhibitors with improved biochemical and physicochemical properties
Bioorganic & Medicinal Chemistry Letters 1995.0
Pyrrolo[2,3-a]carbazoles as Potential Cyclin Dependent Kinase 1 (CDK1) Inhibitors. Synthesis, Biological Evaluation, and Binding Mode through Docking Simulations
Journal of Medicinal Chemistry 2008.0
Aryl[ a ]pyrrolo[3,4- c ]carbazoles as selective cyclin D1-CDK4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2003.0